 relat skin cancer hla antigen renal-transpl recipi background recipi renal allograft risk skin cancer recipi homozyg hla antigen risk certain cancer donor antigen case-control studi relat skin cancer renal-transpl recipi hla homozygos mismatch method patient renal transplant squamous-cel carcinoma basal-cel carcinoma skin transplant hla homozygos recipi hla mismatch result recipi skin cancer relat skin cancer use immunosuppress drug separ case-control influenc exposur sun keratot skin lesion risk skin cancer result risk squamous-cel carcinoma recipi hla-b antigen rel risk percent confid interv percent confid interv antigen mismatch hla-a hla-dr antigen effect risk squamous-cel carcinoma associ mismatch hla loci occurr basal-cel carcinoma total dose azathioprin prednison occurr skin cancer hla exposur keratot skin lesion skin cancer hla homozygos hla-dr frequent patient squamous-cel carcinoma rel risk percent confid interv patient keratot skin lesion rel risk percent confid interv conclus hla-b mismatch risk squamous-cel carcinoma renal-transpl recipi hla-dr homozygos indirect effect level immunosuppress find exposur number keratot skin lesion observ